http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2502785-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2658d45a8e9c71b9598e2bf83242bab3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 |
| filingDate | 1995-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_839862481204376261beac08ff66e1e1 |
| publicationDate | 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2502785-C |
| titleOfInvention | Neisserial mutant strain lacking expression of a glycosyltransferase |
| abstract | The present invention relates to an immunogenic composition or vaccine, Neisserial strain and process for making an oligosaccharide structure from these Neisserial strains. The immunogenic composition comprises an oligosaccharide structure prepared from a recombinant Neisserial strain, said Neisserial strain being incapable of expressing a functionally active form of a glycosyltransferase selected from a group consisting of: lipooligosaccharide glycosyl transferase A (LgtA), the Neisseria gonorrhoeae strain F62 amino acid sequence of which being SEQ ID NO: 3; lipooligosaccharide glycosyl transferase B (LgtB), the Neisseria gonorrhoeae strain F62 amino acid sequence of which being SEQ ID NO: 8; lipooligosaccharide glycosyl transferase C (LgtC), the Neisseria gonorrhoeae strain F62 amino acid sequence of which being SEQ ID NO: 4; lipooligosaccharide glycosyl transferase D (LgtD), the Neisseria gonorrhoeae strain F62 amino acid sequence of which being SEQ ID NO: 5; and lipooligosaccharide glycosyl transferase E (LgtE), the Neisseria gonorrhoeae strain F62 amino acid sequence of which being SEQ ID NO: 6, wherein the functionally active form of the glycosyltransferase catalyzes a reaction selected from the group consisting of: a) adding Gal .beta.1.fwdarw.4 to GlcNAc or Glc; b) adding GalNAc or GlcNAc .beta.1.fwdarw.3 to Gal; and c) adding Gal .alpha.1.fwdarw.4 to Gal. |
| priorityDate | 1994-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1550.